Aggressive choresterol lowing therapy by strong statin from acute phase of acute myocardial infarction.

Aggressive choresterol lowing therapy by strong statin from acute phase of acute myocardial infarction. - ROYAL-AMI

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003893

Enrollment

100

Registered

2010-07-12

Start date

2008-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-segment elevation myocardial infarction

Interventions

rosuvastatin atorvastatin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients admitted with AMI and treated with PCI, accompanied with LDL-C level >70mg/dl.

Exclusion criteria

Exclusion criteria: 1. Familial hyper cholesteremia 2. Cyclospolin taking 3. Liver dysfunction 4. Renal failure 5. Pregnancy or possible 6. Hypothyroidism 7. Hereditary muscle disease 8. Drug or alcohol addiction 9. Hemodynamical Unstable condition

Design outcomes

Primary

Measure	Time frame
MSI(myocardial salvage index) assessed by SPECT	—

Secondary

Measure	Time frame
Various parameters of echocardiography, BNP levels and CoQ10 levels	—

Countries

Japan

Contacts

Public ContactSeigo Sugiyama

Kumamoto University School of Medicine Department of Cardiovascular Medicine

ssugiyam@kumamoto-u.ac.jp096-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026